BioFinance Early Phase 2006 is a one-day program that will feature presentations by the CEOs from 30 life science companies from across Canada and the US. It will also feature panel discussions by experts on topics including early stage financing, aspects of the deal and US financing sources. The presenting companies will be developing new medicines, devices, diagnostics, medical technologies and systems. These companies will likely have some angel, private or seed financing already in place and will be starting the search for investment in the range of up to $ 2 to 5 million.